GYRE THERAPEUTICS, INC. — Form D

GYRE THERAPEUTICS, INC. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-13. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2023-11-13
Form: D
Accession: 0001140361-23-052961
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $5.0M
Amount sold: $5.0M
Investors: 1
Date of first sale: 2023-10-30
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-497103

Issuer

Name: GYRE THERAPEUTICS, INC.
CIK: 0001124105
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 12770 High Bluff Drive, SAN DIEGO, CA, 92130
Phone: 619-949-3681

Officers, directors & promoters (12)

Name	Role	Location
Gordon G Carmichael	Director	San Diego, CA
Thomas Eastling	Director	San Diego, CA
Ying Luo	Director	San Diego, CA
Songjiang Ma	Director	San Diego, CA
Usman G Nassim	Director	San Diego, CA
Renate Parry	Director	San Diego, CA
Charles Wu	Director	San Diego, CA
Han G Ying	Director	San Diego, CA
Ruoyu Chen	Executive Officer	San Diego, CA
Songjiang Ma	Executive Officer	San Diego, CA
Charles Wu	Executive Officer	San Diego, CA
Weiguo Yu	Executive Officer	San Diego, CA

More